<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2023.1211404</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Infection with hypervirulent <italic>Mycobacterium tuberculosis</italic> triggers emergency myelopoiesis but not trained immunity</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Maceiras</surname>
<given-names>Ana Raquel</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<xref ref-type="author-notes" rid="fn004">
<sup>&#x2021;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/390886"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Silv&#xe9;rio</surname>
<given-names>Diogo</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn004">
<sup>&#x2021;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2292324"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gon&#xe7;alves</surname>
<given-names>Rute</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cardoso</surname>
<given-names>Marcos S.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1447309"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Saraiva</surname>
<given-names>Margarida</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/262698"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Instituto de Investiga&#xe7;&#xe3;o e Inova&#xe7;&#xe3;o em Sa&#xfa;de (i3S), Universidade do Porto</institution>, <addr-line>Porto</addr-line>, <country>Portugal</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Instituto de Biologia Molecular e Celular (IBMC), Universidade do Porto</institution>, <addr-line>Porto</addr-line>, <country>Portugal</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Doctoral Program in Molecular and Cell Biology, Instituto de Ci&#xea;ncias Biom&#xe9;dicas Abel Salazar (ICBAS), Universidade do Porto</institution>, <addr-line>Porto</addr-line>, <country>Portugal</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Jayne S. Sutherland, Medical Research Council The Gambia Unit (MRC), Gambia</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Caleb Nwongbouwoh Muefong, The University of Chicago, United States; Belen Garcia-Fojeda, Complutense University of Madrid, Spain</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Margarida Saraiva, <email xlink:href="mailto:margarida.saraiva@ibmc.up.pt">margarida.saraiva@ibmc.up.pt</email>
</p>
</fn>
<fn fn-type="present-address" id="fn003">
<p>&#x2020;Present address: Ana Raquel Maceiras, Wellcome Sanger Institute, Hinxton, United Kingdom</p>
</fn>
<fn fn-type="equal" id="fn004">
<p>&#x2021;These authors have contributed equally to this work and share first authorship</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>13</day>
<month>06</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>14</volume>
<elocation-id>1211404</elocation-id>
<history>
<date date-type="received">
<day>24</day>
<month>04</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>30</day>
<month>05</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Maceiras, Silv&#xe9;rio, Gon&#xe7;alves, Cardoso and Saraiva</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Maceiras, Silv&#xe9;rio, Gon&#xe7;alves, Cardoso and Saraiva</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Introduction</title>
<p>During infection, bone marrow (BM) hematopoiesis is reprogrammed toward myeloid cell production, a mechanism named emergency myelopoiesis. In addition to replenishing myeloid cells, emergency myelopoiesis has been linked to trained immunity, a process that allows enhanced innate immune responses to secondary challenges. Although hematopoietic alterations during tuberculosis (TB) have been described and <italic>Mycobacterium tuberculosis</italic> may colonize the BM, studies using the mouse model of infection and the laboratory reference strain <italic>M. tuberculosis</italic> H37Rv have demonstrated limited emergency myelopoiesis and trained immunity.</p>
</sec> <sec>
<title>Methods</title>
<p>To further address this issue, we aerosol- infected C57BL/6 mice with high doses of the hypervirulent M. tuberculosis isolate HN878 and monitored alterations to the BM. This experimental model better resembles the human blood immune signature of TB.</p>
</sec>
<sec>
<title>Results and discussion</title>
<p>We found increased frequencies of lineage<sup>-</sup>Sca-1<sup>+</sup>cKit<sup>+</sup> (LSK) cells and the granulocyte/macrophage progenitor (GMP) population. At the mature cell level, we observed an increase of monocytes and neutrophils in the blood and lung, likely reflecting the increased BM myeloid output. Monocytes or monocyte-derived macrophages recovered from the BM of <italic>M. tuberculosis</italic> HN878-infected mice did not show signs of trained immunity, suggesting an uncoupling of emergency myelopoiesis and trained immunity in the BM. Surprisingly, <italic>M. tuberculosis</italic> HN878-induced emergency myelopoiesis was not fully dependent on IFN&#x3b3;, as mice lacking this cytokine and infected under the same conditions as wild-type mice still presented BM alterations. These data expand our understanding of the immune response to <italic>M. tuberculosis</italic> and raise awareness of pathogen strain-imposed differences to host responses.</p>
</sec>

</abstract>
<kwd-group>
<kwd>tuberculosis</kwd>
<kwd>myelopoiesis</kwd>
<kwd>trained immunity</kwd>
<kwd>interferon-gamma</kwd>
<kwd>bone marrow</kwd>
</kwd-group>
<contract-sponsor id="cn001">&#x201c;la Caixa&#x201d; Foundation<named-content content-type="fundref-id">10.13039/100010434</named-content>
</contract-sponsor>
<contract-sponsor id="cn002">Funda&#xe7;&#xe3;o para a Ci&#xea;ncia e a Tecnologia<named-content content-type="fundref-id">10.13039/501100001871</named-content>
</contract-sponsor>
<counts>
<fig-count count="3"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="53"/>
<page-count count="12"/>
<word-count count="6710"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Microbial Immunology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>The bone marrow (BM) is highly responsive to stress cues, allowing the rapid adaptation of the hematopoietic process to ensure immune cell replenishment. This adaptation is key during infection and inflammation, in which a deviation of hematopoiesis toward the production of myeloid cells, a process also known as emergency myelopoiesis (EM), is well documented (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>). Recent evidence supports that, in addition to enhanced myeloid cell differentiation, EM plays a role in trained immunity (<xref ref-type="bibr" rid="B3">3</xref>), a mechanism that allows sustained innate immune responses to secondary challenges (<xref ref-type="bibr" rid="B4">4</xref>).</p>
<p>Hematopoietic adaptation has been reported in many infections, including those caused by Mycobacteria. Previous studies showed that, in the murine model, <italic>Mycobacterium avium</italic> infections enhanced the proliferation of hematopoietic stem cells (HSCs) (<xref ref-type="bibr" rid="B5">5</xref>) and that chronic <italic>M. avium</italic> infection caused pancytopenia (<xref ref-type="bibr" rid="B6">6</xref>) and anemia (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>). Furthermore, intradermal administration of <italic>Mycobacterium bovis</italic> BCG, the vaccine used against tuberculosis (TB), induced a transcriptomic rewiring of human stem and progenitor cells toward the myeloid cell lineage (<xref ref-type="bibr" rid="B9">9</xref>). In mice, intravenous administration of BCG caused emergency hematopoiesis and induced trained immunity in macrophages, which became highly protective against <italic>Mycobacterium tuberculosis</italic> (<xref ref-type="bibr" rid="B10">10</xref>). In the case of both <italic>M. avium</italic> and <italic>M. bovis</italic> BCG, interferon (IFN) &#x3b3; was shown to be a key molecule in driving hematopoietic alterations (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>). The impact of IFN&#x3b3; in myelopoiesis is further acknowledged in different scenarios (<xref ref-type="bibr" rid="B12">12</xref>&#x2013;<xref ref-type="bibr" rid="B16">16</xref>). However, IFN&#x3b3; has also been described as a negative modulator of HSC self-renewal, involved in BM failure (<xref ref-type="bibr" rid="B17">17</xref>), indicating that its role as a modulator of hematopoiesis is context dependent.</p>
<p>
<italic>M. tuberculosis</italic> infections caused over 10 million new TB cases and killed over 1.6 million individuals in 2021 alone (<xref ref-type="bibr" rid="B18">18</xref>). Several observations support a possible impact of <italic>M. tuberculosis</italic> in the BM and in deregulating hematopoiesis. <italic>M. tuberculosis</italic> may persist in BM mesenchymal stem cells of TB patients even after antibiotherapy (<xref ref-type="bibr" rid="B19">19</xref>) and in long-term HSCs in individuals with latent TB infection (<xref ref-type="bibr" rid="B20">20</xref>). Additionally, clinical signs of abnormal hematopoiesis, such as anemia and thrombocytopenia, have been reported in TB patients (<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B22">22</xref>). Finally, neutrophilia and altered monocyte/T cell ratios are common in TB and are particularly associated with severe forms of the disease (<xref ref-type="bibr" rid="B23">23</xref>). Aerosol infection of mice with <italic>M. tuberculosis</italic> results in BM colonization (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B24">24</xref>) and the increased recruitment of myeloid cells to the lungs (<xref ref-type="bibr" rid="B25">25</xref>), as well as increased numbers of blood monocytes, which has been shown to be caused by increased egress from the BM (<xref ref-type="bibr" rid="B26">26</xref>). Altogether, observations from human and mouse studies suggest the occurrence of EM during <italic>M. tuberculosis</italic> infections. However, a recent study showed that although <italic>M. tuberculosis</italic> reprogrammed HSCs in mice infected via aerosol, it also limited EM (<xref ref-type="bibr" rid="B24">24</xref>).</p>
<p>Here, we characterize the impact of <italic>M. tuberculosis</italic> infection on the BM using a mouse model previously shown to resemble the human blood immune signature (<xref ref-type="bibr" rid="B27">27</xref>). Specifically, we infected C57BL/6 mice with high doses of <italic>M. tuberculosis</italic> HN878 strain and analyzed the immune cell composition of the lung, blood, and BM at the peak of the disease. Our data show BM alterations compatible with the deviation of hematopoiesis toward myelopoiesis, with an increased output of myeloid cells in the blood and lungs of infected animals. Furthermore, we found that IFN&#x3b3; may be dispensable to this process and despite the BM adaptation to infection, the generated monocytes or macrophages do not acquire an improved capacity to respond to secondary challenges.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<label>2</label>
<title>Materials and methods</title>
<sec id="s2_1">
<label>2.1</label>
<title>Animal housing, infection, and monitoring</title>
<p>C57BL/6 wild-type (WT) or C57BL/6.IFN&#x3b3; deficient (IFN&#x3b3;<sup>-/-</sup>) mice were bred and housed at the i3S Animal House Facility, and infected under ABSL3 conditions. Both male and female mice were used, ranging between 8 and 12 weeks of age at the time of infection. Animals were kept under a controlled temperature (20&#x2013;24&#xb0;C), humidity (45&#x2013;65%), and light cycle (12h light/dark) in specific-pathogen free conditions. Water and food were provided <italic>ad libitum</italic>. Aerosol infection was performed using an inhalation exposure system (Glas-Col) (<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B29">29</xref>). Infection level was determined based on the lung bacterial burden 3 days post-infection: &lt;200 CFUs corresponded to a low dose, while &gt;500 CFUs was considered a high dose. Infected mice were weighed every week or every 2 days upon showing signs of disease. Weight loss of over 20% or lack of responsiveness to physical stimulation were considered humane endpoints, at which point the experiments were terminated. Mice were euthanized by CO<sub>2</sub> inhalation, during which efforts were made to minimize suffering.</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Organ processing</title>
<p>Organs were aseptically excised and processed as described previously (<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B29">29</xref>). Lungs were digested using Collagenase type IV (Gibco, Cat. #17104019) followed by physical disruption and filtering in a 70 &#xb5;m mesh. Blood was collected via cardiac puncture. BM was collected by flushing the tibias and femurs with PBS + 2% FBS (Gibco, Cat. #10500064). Single-cell suspensions were used for bacterial burden determination, flow cytometry, and RNA analysis.</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Bacteria growth and quantification</title>
<p>
<italic>M. tuberculosis</italic> HN878 isolate was grown and stored as described previously (<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B29">29</xref>). Viable bacteria were determined by serial dilution and colony forming unit (CFU) enumeration after 21&#x2013;28 days of incubation at 37&#xb0;C in 7H11 agar plates (Cat. #212203, BD Biosciences). Bacterial quantification in infected lungs and BM was performed upon organ homogenization using the same procedure.</p>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Flow cytometry</title>
<p>Mouse blood, BM, and lung cell suspensions were stained for surface antigens (30&#x2009;min; 4&#xb0;C) and fixed for 20 min in 4% paraformaldehyde-PBS after erythrocyte lysis. For the analysis of BM precursors, the mature lineage (Lin<sup>+</sup>) was depleted using an EasySep&#x2122; Mouse Streptavidin RapidSpheres&#x2122; Isolation Kit (Cat. #19860, STEMCELL Technologies) prior to Lin<sup>-</sup> staining with specific antibodies for precursor and progenitor markers. Dead cells were excluded from the analyses using ZombieAqua (Cat. #423102, Biolegend) or ZombieGreen (Cat. #423112, Biolegend) viability dyes. Cells were acquired on a BD FACS Canto II or BD Fortessa II. Data were analyzed using <italic>FlowJo</italic> (version 10.1.r7). Dimensionality reduction of concatenated data was performed with the <italic>Uniform manifold approximation and projection</italic> (UMAP) <italic>FlowJo</italic> plug-in (version 3.1) (<xref ref-type="bibr" rid="B30">30</xref>). All antibodies used are listed in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1</bold>
</xref>. Gating strategies are shown in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;1A, B</bold>
</xref> and <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;2A</bold>
</xref>.</p>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>RNA extraction and qPCR</title>
<p>Total RNA was extracted from mouse lung or BM cell suspensions using TripleXtractor (Cat. #GB23.0100, GRiSP) and converted to cDNA using a ProtoScript<sup>&#xae;</sup> II First Strand cDNA Synthesis Kit (Cat. #E6560L, NE Biolabs). Relative <italic>CSF2</italic> gene expression quantification was performed using quantitative PCR and Taqman probe assay (Cat. #4331182; Assay ID #Mm01290062_m1, Thermo Fisher Scientific). Normalization of target gene abundance was performed using <italic>Hprt</italic> as the reference gene (Cat. #4331182; Assay ID #Mm03024075_m1, Thermo Fisher Scientific). Gene expression quantification for <italic>Csf1</italic>, <italic>Csf3</italic>, <italic>Tnf</italic>, <italic>Il1b</italic>, <italic>Il6</italic>, <italic>Ifng</italic>, and <italic>Ifnb</italic> was performed using quantitative PCR with SYBR green (Cat. #1725120, Bio-Rad) and intron spanning oligonucleotides specific for the target genes. Normalization of target gene abundance was performed using <italic>Ubiquitin</italic> as the reference gene. Melting and standard curves and RQ values were determined for each gene. Sequences of the oligonucleotides used are in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;2</bold>
</xref>.</p>
</sec>
<sec id="s2_6">
<label>2.6</label>
<title>Histological analysis</title>
<p>Mouse lungs were fixed in 10% buffered formalin and embedded in paraffin. Serial 3-&#xb5;m sections were used for Hematoxylin and Eosin (H&amp;E) or immunofluorescence staining and analysis. Morphometric analysis of lung pathology areas in H&amp;E-stained histological sections was performed using the software <italic>Interactive Learning and Segmentation Toolkit</italic> (<italic>Ilastik</italic> version 1.3.3) and <italic>CellProfiler Analyst</italic> (version 3.1.5). Probability maps for the whole lung and lesion area were created in Ilastik and calculated and analyzed using <italic>CellProfiler Analyst</italic> software (<xref ref-type="bibr" rid="B28">28</xref>). Pathological scoring analysis of H&amp;E-stained histological sections was performed in a blind way, and the histopathological features were scored according to the parameters in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;3</bold>
</xref>.</p>
</sec>
<sec id="s2_7">
<label>2.7</label>
<title>Immunofluorescence</title>
<p>Paraffin-embedded lung sections were stained for myeloperoxidase (Mpo) and nitric oxide synthase (Nos2), as described previously (<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B31">31</xref>). Antigen recovery was performed by incubating slides at 96&#xb0;C in HIER Buffer L (Cat. #TA135HBL, Epredia) for 45 min. Slides were then incubated overnight with goat anti-mouse Mpo (Cat. #AF3667, R&amp;D systems; 1:40) and rabbit anti-mouse Nos2 (M-19, Cat. #sc-650, Santa Cruz Biotechnology, 1:50) at 4&#xb0;C followed by incubation with secondary antibodies donkey anti-goat IgG Alexa Fluor 488 conjugated (Cat. #A-11055, Invitrogen) and donkey anti-rabbit IgG Alexa Fluor 647 conjugated (Cat. #A-31573, Invitrogen) for 2 h at room temperature. Slides were stained with DAPI (Cat. #422801, Biolegend; 1:1000 dilution), and glass coverslips were mounted using Fluoroshield (Cat. #F6182, Sigma-Aldrich). Images were acquired using IN Cell Analyzer 2000 (GE Healthcare) and analyzed using <italic>IN Cell Developer software</italic> (version 1.9) and <italic>ImageJ</italic> (version 1.53t) (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B33">33</xref>).</p>
</sec>
<sec id="s2_8">
<label>2.8</label>
<title>Generation of bone marrow-derived macrophages and purification of bone marrow monocytes</title>
<p>BM-derived macrophages (BMDMs) were generated from BM cellular suspensions as previously described (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B34">34</xref>). Cells were plated in Petri dishes and differentiated into macrophages using DMEM (Cat. #10566016, Gibco), completed with 1% sodium pyruvate (Cat. #S8636, Sigma-Aldrich), 1% HEPES (Cat. #15630106, Gibco), and 10% FBS (Cat. #10500064, Gibco) and supplemented with 20% L-cell conditioned medium (V/V). Once differentiation was complete (7 days), BMDMs were transferred to cell culture plates. BM monocytes were purified from BM cellular suspensions using an EasySep&#x2122; Mouse Monocyte Isolation Kit (Cat. #19861, STEMCELL Technologies), following the manufacturer&#x2019;s protocol, and plated in cell culture plates with RPMI medium (Cat. #61870036, Gibco), completed as described above for DMEM. BMDMs were plated in 96-well plates (100,000 cells per well) for CFU determination or in 24-well plates (500,000 cells per well) for supernatant collection. Purified monocytes (purity &gt;95%) were plated in 96-well plates (100,000 cells per well).</p>
</sec>
<sec id="s2_9">
<label>2.9</label>
<title>Human CD14<sup>+</sup> cell isolation</title>
<p>Peripheral blood was collected and processed to obtain PBMCs as previously described (<xref ref-type="bibr" rid="B34">34</xref>). CD14<sup>+</sup> monocytes were magnetically isolated using CD14 MicroBeads (Cat. #130-050-201, Miltenyi Biotec), following the manufacturer&#x2019;s protocol. Purified cells (100,000 cells per well; purity &gt;95%) were plated in 96-well plates with complete RPMI medium.</p>
</sec>
<sec id="s2_10">
<label>2.10</label>
<title>
<italic>In vitro</italic> infections</title>
<p>Human CD14<sup>+</sup> cells and mouse BMDMs or BM monocytes were infected with <italic>M. tuberculosis</italic> HN878 isolate at a multiplicity of infection (MOI) of 2 (2 bacteria:1 cell). Extracellular bacteria were washed away with PBS after 4 h and bacterial growth was quantified by CFU enumeration 4 h (control) or 4 days after infection. The culture supernatants (BMDMs and BM monocytes) were collected 24 h (in the absence of bacterial washing) after infection for protein quantification.</p>
</sec>
<sec id="s2_11">
<label>2.11</label>
<title>Cytokine quantification</title>
<p>Cytokine production by BMDM or monocyte cultures infected with <italic>M. tuberculosis</italic> was quantified by immunoassay, using commercially available ELISA kits (Cat. #88-7064-88; 88-7013-88; 88-7324-88, Invitrogen). </p>
</sec>
<sec id="s2_12">
<label>2.12</label>
<title>Statistical analysis</title>
<p>Data were plotted and analyzed using <italic>GraphPad Prism</italic> (version 8.1.0): a non-parametric Mann&#x2013;Whitney test was used to compare two groups and Kruskal&#x2013;Wallis one-way analysis of variance test was used for the comparison of more than two groups. Multiple comparison correction was performed using a Dunn post-test. Significant differences are as follows: * p &#x2264; 0.05; ** p &#x2264; 0.01; and *** p &#x2264; 0.001. Spearman correlations and correspondent correlation plots were obtained using <italic>R</italic> (version 4.1.2) and <italic>R</italic> package <italic>corrplot</italic> (version 0.92).</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>Infection with <italic>M. tuberculosis</italic> HN878 strain results in altered cell composition in the lung, blood, and bone marrow</title>
<p>To investigate possible alterations imposed by <italic>M. tuberculosis</italic> infection to the BM hematopoietic output, we aerosol-infected WT C57BL/6 mice with high doses of <italic>M. tuberculosis</italic> HN878. Twenty-seven days post-infection (p.i.), the mice presented a high bacterial burden in the lungs (over 10<sup>9</sup> bacteria) (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>), which was accompanied by marked tissue pathology, with lesions affecting 14% to 56% of the lung (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1B</bold>
</xref>). Additionally, we observed an increase in lung cellularity, associated with the recruitment and accumulation of CD45<sup>+</sup> immune cells (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>). We next analyzed by flow cytometry the myeloid cell composition within the immune cells present in the lung, which accounted for approximately 45% of the total CD45<sup>+</sup> cells (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1D</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1A</bold>
</xref>). Although the frequency of alveolar macrophages decreased with infection, resulting in a very low percentage 27 days p.i., both the frequency and numbers of all other myeloid cell types (monocytes, monocyte-derived recruited macrophages, dendritic cells (DCs), and neutrophils) were significantly increased in infected mice (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1D</bold>
</xref>). Neutrophils exhibited the highest increase both in percentage and cell counts of the myeloid populations analyzed. The global frequency of other immune cells (which included eosinophils and NK, T, and B cells) was not altered (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1D</bold>
</xref>). Immunofluorescence staining of lung sections with Mpo, a neutrophil marker, revealed large Mpo-positive areas, which were dominant compared with those corresponding to Nos2-positive activated macrophages (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1E</bold>
</xref>). These results are in line with previous reports showing an accumulation of myeloid cells, especially neutrophils, in the lungs upon infection with <italic>M. tuberculosis</italic> HN878 (<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B31">31</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Infection with <italic>M. tuberculosis</italic> HN878 is associated with an accumulation of myeloid cells in the lung, blood, and bone marrow. C57BL/6 mice were aerosol-infected with high doses of <italic>M. tuberculosis</italic> isolate HN878. <bold>(A)</bold> Bacterial burden in the lungs determined on day 3 or 27 days post-infection. <bold>(B)</bold> Representative histological images of H&amp;E-stained lung sections from non-infected (NI) or <italic>M. tuberculosis</italic>-infected (HN878) mice. Darker areas corresponding to tissue lesions were quantified to obtain the percentage of area of lesion in the lungs of <italic>M. tuberculosis</italic>-infected mice. <bold>(C)</bold> Number of total cells (left) and immune cells (right) in the lungs of NI or <italic>M. tuberculosis</italic>-infected mice. Immune cells were determined by FACS based on the detection of surface CD45. <bold>(D)</bold> Frequency (left) and total cell counts (right) of distinct myeloid cell populations: monocytes, recruited macrophages (recruited M0), dendritic cells (DCs), alveolar macrophages (alveolar M0), and neutrophils in NI or <italic>M. tuberculosis</italic>-infected mice. Gating strategies are shown in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;1A, B</bold>
</xref>. <bold>(E)</bold> Representative immunofluorescence image of a lung section from an infected mouse (27 days post-infection) stained for myeloperoxidase (Mpo) and nitric oxide synthase 2 (Nos2). Nuclei are stained with DAPI. <bold>(F, G)</bold> Frequency (left) and cell counts (right) of blood <bold>(F)</bold> or bone marrow <bold>(G)</bold> myeloid cell populations in NI or <italic>M. tuberculosis</italic>-infected mice. <bold>(H)</bold> Bacterial burdens in the bone marrow of mice 27 days post-infection. <bold>(I)</bold> Transcription analysis of the indicated genes detected by qPCR in the bone marrow of NI or <italic>M. tuberculosis</italic>-infected mice. Data are mean &#xb1; SEM. Each dot represents an individual mouse, with two independent experiments represented per panel. The infection doses (in CFU &#xb1; SEM)/animal ages (in weeks old at the time of infection) for the experiments used in this figure were 683 &#xb1; 125/10, 1,093 &#xb1; 100/8, and 1057 &#xb1; 74/9 and 10. Non-infected animals were 8 weeks old. The statistical analyses were performed using a Mann&#x2013;Whitney U test to identify statistical differences between groups. p-values inferior to 0.05 were deemed significant: *p-value&lt;0.05, ***p-value&lt;0.001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1211404-g001.tif"/>
</fig>
<p>We then analyzed the blood and BM compartments at 27 days p.i. (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1B</bold>
</xref>). Infected mice presented leukocytosis (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1C</bold>
</xref>), which was associated with increased numbers (per &#xb5;l of blood) of monocytes, neutrophils, and T cells, even though the proportion of T cells in the blood had diminished (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1F</bold>
</xref>). There was a reduction in the frequency of B cells, with no effect on cell numbers (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1F</bold>
</xref>). Thus, the increase in myeloid cells seen in the lungs of infected mice was also observed in the blood, suggesting a possible altered hematopoietic output. Analysis of the BM mature cell populations showed an increase in the frequency and numbers of monocytes, which was accompanied by a decrease in the frequencies and numbers of B cells (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1G</bold>
</xref>). Both neutrophils and T cells remained mostly unaltered (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1G</bold>
</xref>), as did the total number of BM cells (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1D</bold>
</xref>). Importantly, <italic>M. tuberculosis</italic> disseminated into the BM (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1H</bold>
</xref>). Targeted transcriptional analysis of the BM 27 days p.i. showed a modest impact of infection on the expression of cytokine genes involved in hematopoietic reprogramming. <italic>Tnf</italic> and <italic>Csf1</italic> expression was statistically significantly increased and <italic>Csf2</italic> expression was statistically significantly decreased (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1I</bold>
</xref>). The lack of more profound differences in gene expression and the decrease of <italic>Csf2</italic> transcription upon infection was surprising and may reflect the overall exhaustion of the infected BM.</p>
<p>The accumulation of myeloid cells in the lungs of the infected animals, together with the alterations seen in the blood and BM, raise the hypothesis that EM may be happening in this immune compartment.</p>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>
<italic>M. tuberculosis</italic> HN878 infection leads to bone marrow myelopoiesis</title>
<p>To investigate whether EM may be occurring during <italic>M. tuberculosis</italic> HN878 infections, we analyzed the BM progenitor populations of naive versus HN878-infected mice 27 days p.i. (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;2A</bold>
</xref>). UMAP dimensionality reduction analysis of flow cytometry data revealed a different precursor and progenitor cell composition profile between infected and non-infected mice (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>). Closer analysis of the different precursor populations revealed a statistically significant increase of LSK (Lin<sup>-</sup>Sca<sup>+</sup>c-Kit<sup>+</sup>) cells in infected mice (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>). Within the LSK population, long-term HSC (LT-HSC) were not affected by the infection, but an increase of the multipotent progenitors (MPP) 2, 3, and 4 was observed (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>). Moreover, although no statistically significant differences were observed for the frequencies of LK (Lin<sup>-</sup>Sca<sup>-</sup>c-Kit<sup>+</sup>) cells (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref>), there was a statistically significant increase in granulocyte-monocyte progenitors (GMPs) accompanied by a decrease in common myeloid progenitors (CMPs) and megakaryocyte erythrocyte progenitors (MEPs) (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref>). Similar alterations were seen in the frequencies of precursor and progenitor populations (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;2B, C</bold>
</xref>). Altogether, these data suggest the occurrence of EM as a consequence of aerosol infection with high doses of <italic>M. tuberculosis</italic> HN878.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Aerosol infection with high doses of <italic>M. tuberculosis</italic> HN878 leads to emergency myelopoiesis but does not result in trained immunity. Bone marrow cells of C57BL/6 mice aerosol-infected with high doses of <italic>M. tuberculosis</italic> isolate HN878 were recovered and analyzed by flow cytometry <bold>(A&#x2013;C)</bold> or used to investigate trained immunity <bold>(D&#x2013;G)</bold>. Non-infected (NI) mice (8 weeks old) were used as controls. <bold>(A)</bold> UMAP of flow cytometry data overlaying different immune progenitor populations: CMPs (CD34<sup>hi</sup>Fc&#x3b3;R<sup>-</sup>), GMPs (CD34<sup>hi</sup>Fc&#x3b3;R<sup>+</sup>), MEPs (CD34<sup>lo</sup>Fc&#x3b3;R<sup>-</sup>), LT-HSC (Flt3<sup>-</sup>CD150<sup>+</sup>CD48<sup>-</sup>), MPP2 (Flt3<sup>-</sup>CD150<sup>+</sup>CD48<sup>+</sup>), MPP3 (Flt3<sup>-</sup>CD150<sup>-</sup>CD48<sup>+</sup>), and MPP4 (Flt3<sup>+</sup>CD150<sup>-/int</sup>). <bold>(B)</bold> Total cell count of LSK (Lin<sup>-</sup>Sca1<sup>+</sup>c-Kit<sup>+</sup>) progenitor and LSK cell subpopulations: LT-HSC, MPP2, MPP3, and MPP4. <bold>(C)</bold> Total counts of LK (Lin<sup>-</sup>Sca1<sup>-</sup>c-Kit<sup>+</sup>) cells and LK subpopulations: CMPs, GMPs, and MEPs, in the bone marrow. Gating strategies are shown in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;2A</bold>
</xref>. Bone marrow-derived macrophages were generated from NI (closed circles) or <italic>M. tuberculosis</italic> HN878-infected (open squares) mice. Mature cells (day 7 of culture) were infected with the same isolate of <italic>M. tuberculosis</italic> at an MOI of 2. <bold>(D)</bold> Bacterial burdens were determined by CFU enumeration after 4 h and 4 days of infection. <bold>(E)</bold> The production of cytokines TNF&#x3b1;, IL-6, and IL-1&#x3b2; was measured in non-stimulated (NS) or infected (HN878) cell cultures by immunoassay 24 h post-infection. Monocytes were isolated from the bone marrow of NI (closed circles) or <italic>M. tuberculosis</italic>-infected (open squares) mice for <bold>(F)</bold> CFU determination <bold>(F)</bold> or protein analysis <bold>(G)</bold>, as before. <bold>(H)</bold> Monocytes (CD14<sup>+</sup>) were isolated from the blood of IGRA<sup>&#x2212;</sup> healthy donors or active TB patients at presentation (aTB 0) or after 6 months of antibiotherapy (aTB 6), and infected with <italic>M. tuberculosis</italic> for 4 h or 4 days, for bacterial burden determination. The percentage increase of CFU from 4h to 4 days of <italic>in vitro</italic> infection is shown. Data are mean &#xb1; SEM. Each dot represents an individual mouse, distributed in two independent experiments represented per <bold>(B&#x2013;G)</bold> or an individual donor <bold>(H, I)</bold>. The infection doses (in CFU &#xb1; SEM)/animal ages (in weeks old at the time of infection) for the experiments used in this figure were 1,093 &#xb1; 100/8 and 650 &#xb1; 110/8. The statistical analyses were performed using a Mann&#x2013;Whitney U test to identify statistical differences between groups. p-values inferior to 0.05 were deemed significant: *p-value&lt;0.05 and **p-value&lt;0.01.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1211404-g002.tif"/>
</fig>
<p>Given the apparent discrepancy between these data and previously published data (<xref ref-type="bibr" rid="B24">24</xref>), we decided to infect mice with low doses of <italic>M. tuberculosis</italic> HN878. Under these conditions and at day 34 p.i., we still observed colonization of the BM (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;2D</bold>
</xref>), although the bacterial burden was 2 log lower than that resulting from infections with high doses of bacteria. Aerosol infection with low doses of <italic>M. tuberculosis</italic> HN878 did not significantly remodel BM cell composition, as no changes in mature cell populations were observed (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;2E</bold>
</xref>), and only an increase in LSK (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;2F</bold>
</xref>) and a modest decrease in CMPs (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;2G</bold>
</xref>) were observed. Interestingly, a positive correlation was observed between the BM LSK population and lung bacterial burden, monocytes, and neutrophils, as well as BM bacterial burden (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;2H</bold>
</xref>).</p>
<p>Collectively, our findings raise the hypothesis that EM may occur during <italic>M. tuberculosis</italic> infections, possibly associated with more severe outcomes of disease, such as those resulting from high doses of infection.</p>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>
<italic>M. tuberculosis</italic> impact on the bone marrow does not translate into trained immunity</title>
<p>As we observed the adaptation of the BM towards myelopoiesis in our model of aerosol infection with high doses of <italic>M. tuberculosis</italic> HN878, we next investigated whether the resulting mature cells might be trained. As such, we generated macrophages derived from the BM of non-infected or <italic>M. tuberculosis</italic>-infected mice for 27 days. The resulting BMDMs were infected with <italic>M. tuberculosis</italic> HN878 and the bacterial burden was measured 4 h and 4 days p.i. The bacterial burden 4 h after infection was similarly independent of the BMDM origin. Then, an increase in intracellular bacteria was observed over time and was similarly independent of the BMDM origin (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2D</bold>
</xref>), suggesting that previous infection with <italic>M. tuberculosis</italic> did not enhance the protective capacity of <italic>de novo</italic>-generated BMDM. Additionally, we measured the production of TNF&#x3b1;, IL-6, and IL-1&#x3b2;, cytokines associated with trained immunity in the context of mycobacteria (<xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B36">36</xref>), by BMDMs generated from non-infected or infected mice and <italic>in vitro</italic> infected with <italic>M. tuberculosis</italic> HN878. The ability of the generated BMDMs to respond to secondary stimuli was also not enhanced by previous infection across the measured parameters (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2E</bold>
</xref>). Finally, to exclude possible effects imposed on macrophages by the <italic>in vitro</italic> differentiation process, we purified monocytes from the BM of non-infected or <italic>M. tuberculosis</italic>-infected mice and analyzed their microbicidal capacity (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2F</bold>
</xref>) and cytokine response to secondary stimuli (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2G</bold>
</xref>). Monocytes purified from non-infected or infected mice responded similarly, further supporting that despite evidence of EM in the BM, this was not accompanied by training of the mature populations.</p>
<p>As trained immunity was suggested to equip circulating monocytes from individuals recently exposed to <italic>M. tuberculosis</italic> with an increased capacity to control BCG (<xref ref-type="bibr" rid="B37">37</xref>), we considered the hypothesis that trained immunity may occur at the periphery. To test this hypothesis, we started by comparing the bacterial growth over a 4-day period in monocytes isolated from IGRA<bold>
<sup>&#x2212;</sup>
</bold> or active TB patients. In IGRA<bold>
<sup>&#x2212;</sup>
</bold> monocytes the bacteria were able to grow; however, this growth was much more limited in the case of active TB monocytes (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2H</bold>
</xref>). Moreover, when we compared the ability of monocytes from active TB patients to control <italic>M. tuberculosis</italic> before and after antibiotherapy, we found that after treatment the growth of bacteria was superior for all tested donors (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2I</bold>
</xref>).</p>
<p>Altogether, our data demonstrate that in a mouse model mimicking the human transcriptional signature of TB, BM monocytes or macrophages did not acquire trained immunity despite the occurrence of EM. However, untreated active TB in humans appeared to associate with circulating monocytes that display an increased capacity to control <italic>M. tuberculosis</italic> growth in <italic>in vitro</italic> infections.</p>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>Impact of IFN&#x3b3; deficiency on emergency myelopoiesis upon infection with <italic>M. tuberculosis</italic> HN878</title>
<p>As IFN&#x3b3; has been widely implicated in EM (<xref ref-type="bibr" rid="B38">38</xref>, <xref ref-type="bibr" rid="B39">39</xref>) and we observed an increase of the expression of this cytokine in the BM of <italic>M. tuberculosis</italic>HN878-infected mice (<xref ref-type="fig" rid="f1"><bold>Figure 1I</bold></xref>), we sought to investigate whether its presence was required for the EM observed in the C57BL/6 model of infection. Thus, we aerosol-infected C57BL/6 WT and IFN&#x3b3;<sup>-/-</sup> mice with a high dose of <italic>M. tuberculosis</italic> HN878. IFN&#x3b3;<sup>-/-</sup> mice presented higher lung bacterial burdens than WT mice, in agreement with their known inability to cope with <italic>M. tuberculosis</italic> infections (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>). In the same line, histological analysis revealed more extensive lesions in IFN&#x3b3;<sup>-/-</sup> mice than in WT mice, with damaged tissue and pulmonary exudate visible in areas adjacent to lesions (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>). Both the percentage of lesion (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>) and the lesion score (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3D</bold>
</xref>) were increased in infected IFN&#x3b3;<sup>-/-</sup> mice compared with WT mice. A lack of IFN&#x3b3; did not impact the number of total or immune (CD45<sup>+</sup>) lung cells (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3E</bold>
</xref>). The numbers of monocytes, recruited macrophages, and neutrophils present in the lungs of IFN&#x3b3; competent or deficient mice were also similar (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3F</bold>
</xref>). Despite this overall similarity in myeloid cell composition in the lungs of infected WT and IFN&#x3b3;<sup>-/-</sup> mice, the increase of monocytes and neutrophils seen in the blood of infected WT mice was not observed in the absence of IFN&#x3b3; (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3G</bold>
</xref>). We then focused on analyzing the BM compartment. As observed in the lung, IFN&#x3b3;<sup>-/-</sup> mice presented a higher bacterial burden in the BM than WT mice (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3H</bold>
</xref>), with BM cellularity (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3I</bold>
</xref>) and the variations in the number of monocytes (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3J</bold>
</xref>) similar in the two mouse strains. However, IFN&#x3b3;<sup>-/-</sup> mice exhibited a reduction in BM neutrophils compared with WT mice (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3J</bold>
</xref>). These data indicate that, in the absence of IFN&#x3b3;, the accumulation of monocytes and neutrophils observed in the lung is not fully reflected in the blood and the BM, as seen for WT mice. Although this finding is not fully understood, it may suggest a faster recruitment of neutrophils to the lung, with increased exit rates from the BM, or alternatively an increased lifespan of neutrophils in the lung.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Role of IFN&#x3b3; in <italic>M. tuberculosis</italic>-induced emergency hematopoiesis. C57BL/6 WT or IFN&#x3b3;<sup>-/-</sup> mice were aerosol-infected with high doses of <italic>M. tuberculosis</italic> isolate HN878. When animals reached humane endpoints the experiment was terminated. This happened between days 24 and 27 post-infection. At these time points, the bacterial burden in the lungs was determined <bold>(A)</bold>. <bold>(B)</bold> Representative histological images of H&amp;E-stained lung sections from <italic>M. tuberculosis</italic>-infected WT or IFN&#x3b3;<sup>-/-</sup> mice. Zoomed areas show lesion-adjacent tissue. <bold>(C)</bold> Morphometric quantification of the percentage of lesion in the lung section. <bold>(D)</bold> Histopathological score attributed to each lesion. <bold>(E)</bold> Number of total cells (left) and immune cells (right) in the lungs of NI or <italic>M. tuberculosis</italic>-infected mice. Immune cells were determined by FACS based on the detection of surface CD45. <bold>(F)</bold> Number of monocytes, recruited macrophages, and neutrophils in NI or <italic>M. tuberculosis</italic>-infected mice. Gating strategies are shown in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;1A, B</bold>
</xref>. <bold>(G)</bold> Monocyte and neutrophil cell counts per &#xb5;l of blood of NI or <italic>M. tuberculosis</italic>-infected mice. <bold>(H)</bold> Bacterial burdens in the bone marrow of WT or IFN&#x3b3;<sup>-/-</sup> mice 24&#x2013;27 days post-infection. <bold>(I, J)</bold> Total cell numbers <bold>(I)</bold> and numbers of monocytes and neutrophils <bold>(J)</bold> in the bone marrow of NI and infected mice. <bold>(K)</bold> UMAP of flow cytometry data overlaying different immune progenitor populations: CMPs (CD34<sup>hi</sup>Fc&#x3b3;R<sup>-</sup>), GMPs (CD34<sup>hi</sup>Fc&#x3b3;R<sup>+</sup>), MEPs (CD34<sup>lo</sup>Fc&#x3b3;R<sup>-</sup>), LT-HSC (Flt3<sup>-</sup>CD150<sup>+</sup>CD48<sup>-</sup>), MPP2 (Flt3<sup>-</sup>CD150<sup>+</sup>CD48<sup>+</sup>), MPP3 (Flt3<sup>-</sup>CD150<sup>-</sup>CD48<sup>+</sup>), and MPP4 (Flt3<sup>+</sup>CD150<sup>-/int</sup>). <bold>(L)</bold> Total cell count of LSK (Lin<sup>-</sup>Sca1<sup>+</sup>c-Kit<sup>+</sup>) progenitor and LSK cell subpopulations: LT-HSC, MPP2, MPP3, and MPP4. <bold>(M)</bold> Total counts of LK (Lin<sup>-</sup>Sca1<sup>-</sup>c-Kit<sup>+</sup>) cells and LK subpopulations: CMPs, GMPs, and MEPs, in the bone marrow. Gating strategies are shown in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;2A</bold>
</xref>. <bold>(N)</bold> Transcription analysis of the indicated genes detected by qPCR in the bone marrow of NI or <italic>M. tuberculosis</italic>-infected WT or IFN&#x3b3;<sup>-/-</sup> mice. Data are mean &#xb1; SEM. Each dot represents an individual mouse, distributed in two independent experiments represented per panel. The infection doses (in CFU &#xb1; SEM)/animal ages (in weeks old at the time of infection) for the experiments used in this figure were 1,093 &#xb1; 100/8 for WT and 11&#x2013;12 for IFN&#x3b3;<sup>-/-</sup> and 1,057 &#xb1; 74/9&#x2013;10 for WT and 9 for IFN&#x3b3;<sup>-/-</sup>. Non-infected animals were 10&#x2013;11 weeks old. The statistical analyses were performed using a Mann&#x2013;Whitney U test when comparing only two groups, or a Kruskal&#x2013;Wallis one-way analysis of variance to identify statistical differences between groups. p-values inferior to 0.05 were deemed significant: *p-value&lt;0.05, **p-value&lt;0.01, and ***p-value&lt;0.001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1211404-g003.tif"/>
</fig>
<p>Next, we questioned whether EM would occur in IFN&#x3b3;<sup>-/-</sup> mice upon <italic>M. tuberculosis</italic> HN878 infection. Similar to the WT controls, UMAP reduction analysis of flow cytometry data disclosed differences in precursor and progenitor cell composition profiles between infected and non-infected IFN&#x3b3;<sup>-/-</sup> mice (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3K</bold>
</xref>). The analysis of precursor populations revealed an overall similar tendency between WT and IFN&#x3b3;<sup>-/-</sup> mice upon infection, with an increase of all populations in infected mice compared with uninfected mice (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3L</bold>
</xref>). However, for some populations, such as LSK, MPP2, and MPP3, this increase was less marked in the case of IFN&#x3b3;<sup>-/-</sup> mice, (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3L</bold>
</xref>). A similar profile was observed in progenitor populations, with less pronounced alterations seen in IFN&#x3b3;<sup>-/-</sup> mice (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3M</bold>
</xref>). Of note, the most marked change observed in IFN&#x3b3;<sup>-/-</sup> mice upon infection was an increase in the GMP population (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3M</bold>
</xref>). Similar findings were observed in terms of cell population frequencies (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;3</bold>
</xref>). Altogether, these findings suggest that EM in response to severe <italic>M. tuberculosis</italic> infections might occur, at least to some extent, even in the absence of IFN&#x3b3;. EM has been linked to inflammatory environments in the BM (<xref ref-type="bibr" rid="B40">40</xref>). Thus, we questioned whether the lack of IFN&#x3b3; would alter the inflammatory environment seen in the BM of infected WT mice (<xref ref-type="fig" rid="f1">
<bold>Figure 1I</bold>
</xref>). Interestingly, the transcription of several cytokine genes in the BM was decreased in infected IFN&#x3b3;<sup>-/-</sup> mice compared with WT or uninfected mice (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3N</bold>
</xref>). However, this was not the case for TNF (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3N</bold>
</xref>), the transcription of which was enhanced by the infection independently of IFN&#x3b3; (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3N</bold>
</xref>).</p>
<p>Together these data suggest that IFN&#x3b3; is partly dispensable for the occurrence of EM upon the infection of mice with <italic>M. tuberculosis</italic> HN878, consequently suggesting the occurrence of alternative mechanisms.</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>TB remains a major health problem, with increasing numbers of new cases and fatalities reported over the past 2 years (<xref ref-type="bibr" rid="B18">18</xref>). Neutrophils have been consistently associated with poor outcomes of TB in humans and experimental models of TB (<xref ref-type="bibr" rid="B41">41</xref>, <xref ref-type="bibr" rid="B42">42</xref>). Accompanying the enhanced neutrophil blood signature present in TB patients (<xref ref-type="bibr" rid="B43">43</xref>), an under-abundance of B cell, NK cell, and effector T cell signatures was also identified in active TB, progression from latent TB, and TB-susceptible mice (<xref ref-type="bibr" rid="B27">27</xref>). Decreased levels of mRNAs associated with lymphocyte lineages and increased expression of those associated with myeloid differentiation were also associated with progression from latent to active TB (<xref ref-type="bibr" rid="B44">44</xref>). Thus, a myeloid-biased remodeling of the hematopoietic landscape likely accompanies TB disease progression and establishment, which may at least partially result from the adaptation of the BM to the infection, as seen in other infection and inflammatory settings (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B45">45</xref>). To experimentally address this hypothesis, we characterized the alterations imposed by <italic>M. tuberculosis</italic> infection on the mature and progenitor cellular populations in the BM. As such, C57BL/6 mice were aerosol-infected with high doses of <italic>M. tuberculosis</italic> isolate HN878. This experimental condition results in severe TB disease and is the one condition to better recapitulate the blood transcriptomic signatures of TB patients in the mouse C57BL/6 genetic background (<xref ref-type="bibr" rid="B27">27</xref>). The <italic>M. tuberculosis</italic> HN878 isolate has been described as hypervirulent as a result of enhanced induction of type I IFN and deregulated Th1 immunity (<xref ref-type="bibr" rid="B46">46</xref>, <xref ref-type="bibr" rid="B47">47</xref>). More recently, infections with <italic>M. tuberculosis</italic> HN878 were also shown to lead to neutrophil overactivation by type I IFN, with exacerbated NETosis formation and extensive tissue pathology (<xref ref-type="bibr" rid="B31">31</xref>).</p>
<p>We observed alterations to the BM cell progenitor composition, namely an increased frequency of LSK and GMP cell populations, together with a decrease in the CMP population. Furthermore, we also observed an expansion of monocytes in the BM, blood, and lung and of neutrophils in the blood and lung. Altogether, our data support the occurrence of EM as a consequence of <italic>M. tuberculosis</italic> infection. Additionally, a previous study identified an increase in the LSK population but not in GMPs upon <italic>M. tuberculosis</italic> infection (<xref ref-type="bibr" rid="B24">24</xref>). However, in that study, a different strain of <italic>M. tuberculosis</italic>, the laboratory reference strain H37Rv, was used and the aerosol infection was performed with low bacilli doses, which results in a milder outcome of infection, with the mice surviving for long time periods and presenting lower bacterial burdens in the lungs and BM (<xref ref-type="bibr" rid="B24">24</xref>). Most notably, the blood transcriptional signature observed in TB patients was not reproduced in such experimental conditions (<xref ref-type="bibr" rid="B27">27</xref>). Therefore, it is likely that the discrepancies seen in terms of GMP dynamics upon infection are reflecting the severity of the infection and contributing to the characteristic TB blood immune signature. In line with this, we show that infections of mice with low doses of <italic>M. tuberculosis</italic> HN878 did result in BM colonization but not in EM. Additionally, it is important to emphasize that infections with the <italic>M. tuberculosis</italic> HN878 isolate, such as those performed in this study, induce a relatively rapid progression to disease and may thus be reflecting the peak of active TB, rather than a long-term chronic infection. The differences seen in the GMP dynamics between high and low doses of infection, or between isolates of distinct virulence, may also reflect BM adaptation to these two different settings: peak of TB disease vs. chronic TB infection.</p>
<p>Independently of the distinct BM adaptation to infections by the different <italic>M. tuberculosis</italic> isolates, a common point is the resulting impaired trained immunity. In fact, we observed decreased cytokine production in response to secondary challenge by monocytes isolated from infected BM. It is possible that the environment the BM is subjected to by hypervirulent strains of <italic>M. tuberculosis</italic> may promote innate cell tolerance. This is an intriguing question worth investigating in the future. Interestingly, trained immunity has previously been suggested to equip monocytes from individuals recently exposed to <italic>M. tuberculosis</italic> with increased capacity to control BCG (<xref ref-type="bibr" rid="B37">37</xref>). By comparing the ability of monocytes purified from IGRA<bold>
<sup>&#x2212;</sup>
</bold> donors or from active TB patients at presentation or post-treatment, we also report that the best controllers of <italic>M. tuberculosis</italic> growth are monocytes from active TB patients before treatment. Therefore, it is tempting to speculate that training of myeloid cells in the context of <italic>M. tuberculosis</italic> may be achieved in the periphery rather than in the BM. Related to this, training of alveolar macrophages has been described in several studies, namely upon viral infection (<xref ref-type="bibr" rid="B48">48</xref>&#x2013;<xref ref-type="bibr" rid="B50">50</xref>). Further exploring these questions using genetically distinct isolates of <italic>M. tuberculosis</italic> and strains of mice is exciting, as uncovering potential mechanisms of trained immunity in circulating monocytes and resident macrophages may unleash novel strategies to tackle TB.</p>
<p>The mechanisms underlying BM adaptation during TB, and how they may articulate with immunity at the site of infection, remain elusive. In line with several previous studies (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B24">24</xref>), we show colonization of the BM by <italic>M. tuberculosis</italic>. Thus, the presence of the bacteria in the BM may directly impact on the hematopoietic skewing, e.g., by activating pattern recognition receptors expressed on HSCs or progenitor cells (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B45">45</xref>). On the other hand, the local and systemic inflammatory response caused by the infection may play a key role in modulating the hematopoietic niche and prioritizing myelopoiesis. Indeed, several cytokines have been described to modulate myelopoiesis, including type I and type II IFNs, IL-1, TNF&#x3b1;, IL-6, IL-27, and colony stimulating factors (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B45">45</xref>). Analysis of the transcription of several of these molecules in the BM upon infection with high doses of <italic>M. tuberculosis</italic> HN878 revealed only modest changes. However, as we are analyzing bulk RNA and one time point only, we cannot exclude an elevation of some of these or other molecules in the BM niche over time. Of note, IFN&#x3b3; has been shown to play such a role in the context of <italic>M. avium</italic> and <italic>M. bovis</italic> BCG infections (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B10">10</xref>), but not in other settings (<xref ref-type="bibr" rid="B17">17</xref>), which suggests a context-dependent action. In the context of aerosol infection with high doses of <italic>M. tuberculosis</italic> HN878, IFN&#x3b3; appears to be partly dispensable. It is possible that the excessive inflammation resulting from infections by <italic>M. tuberculosis</italic> HN878 may surpass on one hand the requirement of IFN&#x3b3; for myelopoiesis, as seen in BCG (<xref ref-type="bibr" rid="B10">10</xref>), and on the other hand, the limiting effect of type I IFN, as seen in <italic>M. tuberculosis</italic> H37Rv infections (<xref ref-type="bibr" rid="B24">24</xref>). Whether the global alteration to the hematopoietic niche or a particular cytokine are key effectors in our setting remains to be addressed. The most marked alteration in the BM of infected IFN&#x3b3;<sup>-/-</sup> mice was the pronounced increase of GMPs. This is interesting because even though neutrophils accumulated in the lungs of these mice, an increase of these cells in the blood was not observed. In addition to the differential recruitment of neutrophils to the lungs of IFN&#x3b3;<sup>-/-</sup> mice, it is also conceivable that the full differentiation of GMPs is not achieved in the absence of IFN&#x3b3;. Finally, it is worth mentioning that compared with WT mice, IFN&#x3b3;<sup>-/-</sup> mice show increased lung bacterial burdens and lesion scores in the absence of increased cellularity. It is possible that a lack of IFN&#x3b3; in infections with <italic>M. tuberculosis</italic> HN878 may not impact the already high amount of neutrophils in the lung described for this isolate (<xref ref-type="bibr" rid="B31">31</xref>) but contribute to the worsening of lesions by failing to control neutrophil responses, as described in the context of <italic>M. tuberculosis</italic> H37Rv infections (<xref ref-type="bibr" rid="B51">51</xref>).</p>
<p>In conclusion, this study adds to the expanding evidence linking BM alterations to myeloid/lymphoid imbalances in TB. Understanding the crosstalk between central hematopoiesis and local immune responses may provide novel insights into the immune response to TB, which is an important driver of TB disease. This may in turn benefit the design of novel host-directed therapies (<xref ref-type="bibr" rid="B52">52</xref>, <xref ref-type="bibr" rid="B53">53</xref>), which are acknowledged as promising strategies to mitigate TB severity and mortality.</p>
</sec>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Material</bold>
</xref>. Further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The study protocol leading to peripheral blood mononuclear cells (PBMC) isolation was approved by the Health Ethics Committees of the Centro Universit&#xe1;rio Hospitalar de S. Jo&#xe3;o (approval number 109-11), the North Health Region Administration (approval number 71-2014) and the Portuguese Data Protection Authority (approval number 12174-2011). To ensure confidentiality, each case was anonymized by the assignment of a random identification number. Participants were enrolled at a TB clinic in Porto and provided informed consent. Experiments were conducted according to the principles expressed in the Declaration of Helsinki. The patients/participants provided their written informed consent to participate in this study. Animal experiments followed the 2010/63/EU Directive and were approved by the i3S Animal Ethics Committee and the Portuguese National Authority for Animal Health (DGAV; #018413/2021-11-24).</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>AM, DS, and MS designed the experiments, analyzed the data, and wrote the manuscript; AM, DS, RG, and MC performed the experiments; MS obtained funding. All authors contributed to the article and approved the submitted version.</p>
</sec>
</body>
<back>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>This work has been funded by La Caixa Foundation (HR21-00415) and the Portuguese Foundation for Science and Technology (FCT) (PTDC/SAU-INF/1172/2021) to MS. DS and RG hold FCT PhD fellowships with references SFRH/BD/143536/2019 and 2022.12852.BD, respectively. MS is funded by FCT through CEECIND/00241/2017.</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>We acknowledge the i3S scientific platforms Translational Cytometry and Animal House. We thank Prof. Gil Castro for critically reading the manuscript.</p>
</ack>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fimmu.2023.1211404/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fimmu.2023.1211404/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet_1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manz</surname> <given-names>MG</given-names>
</name>
<name>
<surname>Boettcher</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Emergency granulopoiesis</article-title>. <source>Nat Rev Immunol</source> (<year>2014</year>) <volume>14</volume>:<page-range>302&#x2013;14</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nri3660</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schultze</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Mass</surname> <given-names>E</given-names>
</name>
<name>
<surname>Schlitzer</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Emerging principles in myelopoiesis at homeostasis and during infection and inflammation</article-title>. <source>Immunity</source> (<year>2019</year>) <volume>50</volume>:<fpage>288</fpage>&#x2013;<lpage>301</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.immuni.2019.01.019</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mitroulis</surname> <given-names>I</given-names>
</name>
<name>
<surname>Ruppova</surname> <given-names>K</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>B</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>L-S</given-names>
</name>
<name>
<surname>Grzybek</surname> <given-names>M</given-names>
</name>
<name>
<surname>Grinenko</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Modulation of myelopoiesis progenitors is an integral component of trained immunity</article-title>. <source>Cell</source> (<year>2018</year>) <volume>172</volume>:<fpage>147</fpage>&#x2013;<lpage>161.e12</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2017.11.034</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Netea</surname> <given-names>MG</given-names>
</name>
<name>
<surname>Joosten</surname> <given-names>LAB</given-names>
</name>
<name>
<surname>Latz</surname> <given-names>E</given-names>
</name>
<name>
<surname>Mills</surname> <given-names>KHG</given-names>
</name>
<name>
<surname>Natoli</surname> <given-names>G</given-names>
</name>
<name>
<surname>Stunnenberg</surname> <given-names>HG</given-names>
</name>
<etal/>
</person-group>. <article-title>Trained immunity: a program of innate immune memory in health and disease</article-title>. <source>Science</source> (<year>2016</year>) <volume>352</volume>:<fpage>aaf1098</fpage>. doi: <pub-id pub-id-type="doi">10.1126/science.aaf1098</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baldridge</surname> <given-names>MT</given-names>
</name>
<name>
<surname>King</surname> <given-names>KY</given-names>
</name>
<name>
<surname>Boles</surname> <given-names>NC</given-names>
</name>
<name>
<surname>Weksberg</surname> <given-names>DC</given-names>
</name>
<name>
<surname>Goodell</surname> <given-names>MA</given-names>
</name>
</person-group>. <article-title>Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection</article-title>. <source>Nature</source> (<year>2010</year>) <volume>465</volume>:<page-range>793&#x2013;7</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nature09135</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matatall</surname> <given-names>KA</given-names>
</name>
<name>
<surname>Jeong</surname> <given-names>M</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>S</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>D</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>F</given-names>
</name>
<name>
<surname>Mo</surname> <given-names>Q</given-names>
</name>
<etal/>
</person-group>. <article-title>Chronic infection depletes hematopoietic stem cells through stress-induced terminal differentiation</article-title>. <source>Cell Rep</source> (<year>2016</year>) <volume>17</volume>:<page-range>2584&#x2013;95</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.celrep.2016.11.031</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodrigues</surname> <given-names>PN</given-names>
</name>
<name>
<surname>Gomes</surname> <given-names>SS</given-names>
</name>
<name>
<surname>Neves</surname> <given-names>JV</given-names>
</name>
<name>
<surname>Gomes-Pereira</surname> <given-names>S</given-names>
</name>
<name>
<surname>Correia-Neves</surname> <given-names>M</given-names>
</name>
<name>
<surname>Nunes-Alves</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Mycobacteria-induced anaemia revisited: a molecular approach reveals the involvement of NRAMP1 and lipocalin-2, but not of hepcidin</article-title>. <source>Immunobiology</source> (<year>2011</year>) <volume>216</volume>:<page-range>1127&#x2013;34</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.imbio.2011.04.004</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gomes</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Moreira</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Silva</surname> <given-names>T</given-names>
</name>
<name>
<surname>Neves</surname> <given-names>JV</given-names>
</name>
<name>
<surname>Mesquita</surname> <given-names>G</given-names>
</name>
<name>
<surname>Almeida</surname> <given-names>AA</given-names>
</name>
<etal/>
</person-group>. <article-title>IFN-&#x3b3;-Dependent reduction of erythrocyte life span leads to anemia during mycobacterial infection</article-title>. <source>J Immunol</source> (<year>2019</year>) <volume>203</volume>:<page-range>2485&#x2013;96</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.1900382</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cirovic</surname> <given-names>B</given-names>
</name>
<name>
<surname>de Bree</surname> <given-names>LCJ</given-names>
</name>
<name>
<surname>Groh</surname> <given-names>L</given-names>
</name>
<name>
<surname>Blok</surname> <given-names>BA</given-names>
</name>
<name>
<surname>Chan</surname> <given-names>J</given-names>
</name>
<name>
<surname>van der Velden</surname> <given-names>WJFM</given-names>
</name>
<etal/>
</person-group>. <article-title>BCG Vaccination in humans elicits trained immunity via the hematopoietic progenitor compartment</article-title>. <source>Cell Host Microbe</source> (<year>2020</year>) <volume>28</volume>:<fpage>322</fpage>&#x2013;<lpage>334.e5</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.chom.2020.05.014</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaufmann</surname> <given-names>E</given-names>
</name>
<name>
<surname>Sanz</surname> <given-names>J</given-names>
</name>
<name>
<surname>Dunn</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Khan</surname> <given-names>N</given-names>
</name>
<name>
<surname>Mendon&#xe7;a</surname> <given-names>LE</given-names>
</name>
<name>
<surname>Pacis</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>BCG Educates hematopoietic stem cells to generate protective innate immunity against tuberculosis</article-title>. <source>Cell</source> (<year>2018</year>) <volume>172</volume>:<fpage>176</fpage>&#x2013;<lpage>190.e19</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2017.12.031</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feng</surname> <given-names>CG</given-names>
</name>
<name>
<surname>Weksberg</surname> <given-names>DC</given-names>
</name>
<name>
<surname>Taylor</surname> <given-names>GA</given-names>
</name>
<name>
<surname>Sher</surname> <given-names>A</given-names>
</name>
<name>
<surname>Goodell</surname> <given-names>MA</given-names>
</name>
</person-group>. <article-title>The p47 GTPase lrg-47 (Irgm1) links host defense and hematopoietic stem cell proliferation</article-title>. <source>Cell Stem Cell</source> (<year>2008</year>) <volume>2</volume>:<page-range>83&#x2013;9</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.stem.2007.10.007</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Belyaev</surname> <given-names>NN</given-names>
</name>
<name>
<surname>Brown</surname> <given-names>DE</given-names>
</name>
<name>
<surname>Diaz</surname> <given-names>A-IG</given-names>
</name>
<name>
<surname>Rae</surname> <given-names>A</given-names>
</name>
<name>
<surname>Jarra</surname> <given-names>W</given-names>
</name>
<name>
<surname>Thompson</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Induction of an IL7-R(+)c-Kit(hi) myelolymphoid progenitor critically dependent on IFN-gamma signaling during acute malaria</article-title>. <source>Nat Immunol</source> (<year>2010</year>) <volume>11</volume>:<page-range>477&#x2013;85</page-range>. doi: <pub-id pub-id-type="doi">10.1038/ni.1869</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sch&#xfc;rch</surname> <given-names>CM</given-names>
</name>
<name>
<surname>Riether</surname> <given-names>C</given-names>
</name>
<name>
<surname>Ochsenbein</surname> <given-names>AF</given-names>
</name>
</person-group>. <article-title>Cytotoxic CD8+ T cells stimulate hematopoietic progenitors by promoting cytokine release from bone marrow mesenchymal stromal cells</article-title>. <source>Cell Stem Cell</source> (<year>2014</year>) <volume>14</volume>:<page-range>460&#x2013;72</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.stem.2014.01.002</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cardoso</surname> <given-names>A</given-names>
</name>
<name>
<surname>Martins</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Maceiras</surname> <given-names>AR</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Castro</surname> <given-names>I</given-names>
</name>
<name>
<surname>Castro</surname> <given-names>AG</given-names>
</name>
<etal/>
</person-group>. <article-title>Interleukin-10 induces interferon-&#x3b3;-dependent emergency myelopoiesis</article-title>. <source>Cell Rep</source> (<year>2021</year>) <volume>37</volume>:<fpage>109887</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.celrep.2021.109887</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Bruin</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Libregts</surname> <given-names>SF</given-names>
</name>
<name>
<surname>Valkhof</surname> <given-names>M</given-names>
</name>
<name>
<surname>Boon</surname> <given-names>L</given-names>
</name>
<name>
<surname>Touw</surname> <given-names>IP</given-names>
</name>
<name>
<surname>Nolte</surname> <given-names>MA</given-names>
</name>
</person-group>. <article-title>IFN&#x3b3; induces monopoiesis and inhibits neutrophil development during inflammation</article-title>. <source>Blood</source> (<year>2012</year>) <volume>119</volume>:<page-range>1543&#x2013;54</page-range>. doi: <pub-id pub-id-type="doi">10.1182/blood-2011-07-367706</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>MacNamara</surname> <given-names>KC</given-names>
</name>
<name>
<surname>Oduro</surname> <given-names>K</given-names>
</name>
<name>
<surname>Martin</surname> <given-names>O</given-names>
</name>
<name>
<surname>Jones</surname> <given-names>DD</given-names>
</name>
<name>
<surname>McLaughlin</surname> <given-names>M</given-names>
</name>
<name>
<surname>Choi</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Infection-induced myelopoiesis during intracellular bacterial infection is critically dependent upon IFN-&#x3b3; signaling</article-title>. <source>J Immunol</source> (<year>2011</year>) <volume>186</volume>:<page-range>1032&#x2013;43</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.1001893</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Bruin</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Demirel</surname> <given-names>&#xd6;</given-names>
</name>
<name>
<surname>Hooibrink</surname> <given-names>B</given-names>
</name>
<name>
<surname>Brandts</surname> <given-names>CH</given-names>
</name>
<name>
<surname>Nolte</surname> <given-names>MA</given-names>
</name>
</person-group>. <article-title>Interferon-&#x3b3; impairs proliferation of hematopoietic stem cells in mice</article-title>. <source>Blood</source> (<year>2013</year>) <volume>121</volume>:<page-range>3578&#x2013;85</page-range>. doi: <pub-id pub-id-type="doi">10.1182/blood-2012-05-432906</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="book">
<person-group person-group-type="author">
<collab>World Health Organization</collab>
</person-group>. <source>Global tuberculosis report 2022</source>. <publisher-loc>Geneve</publisher-loc>: <publisher-name>WHO</publisher-name> (<year>2022</year>). Available at: <uri xlink:href="https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022">https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022</uri>.</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Das</surname> <given-names>B</given-names>
</name>
<name>
<surname>Kashino</surname> <given-names>SS</given-names>
</name>
<name>
<surname>Pulu</surname> <given-names>I</given-names>
</name>
<name>
<surname>Kalita</surname> <given-names>D</given-names>
</name>
<name>
<surname>Swami</surname> <given-names>V</given-names>
</name>
<name>
<surname>Yeger</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>CD271(+) bone marrow mesenchymal stem cells may provide a niche for dormant mycobacterium tuberculosis</article-title>. <source>Sci Transl Med</source> (<year>2013</year>) <volume>5</volume>:<fpage>170ra13</fpage>. doi: <pub-id pub-id-type="doi">10.1126/scitranslmed.3004912</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tornack</surname> <given-names>J</given-names>
</name>
<name>
<surname>Reece</surname> <given-names>ST</given-names>
</name>
<name>
<surname>Bauer</surname> <given-names>WM</given-names>
</name>
<name>
<surname>Vogelzang</surname> <given-names>A</given-names>
</name>
<name>
<surname>Bandermann</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zedler</surname> <given-names>U</given-names>
</name>
<etal/>
</person-group>. <article-title>Human and mouse hematopoietic stem cells are a depot for dormant mycobacterium tuberculosis</article-title>. <source>PloS One</source> (<year>2017</year>) <volume>12</volume>:<elocation-id>e0169119</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0169119</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Minchella</surname> <given-names>PA</given-names>
</name>
<name>
<surname>Donkor</surname> <given-names>S</given-names>
</name>
<name>
<surname>Owolabi</surname> <given-names>O</given-names>
</name>
<name>
<surname>Sutherland</surname> <given-names>JS</given-names>
</name>
<name>
<surname>McDermid</surname> <given-names>JM</given-names>
</name>
</person-group>. <article-title>Complex anemia in tuberculosis: the need to consider causes and timing when designing interventions</article-title>. <source>Clin Infect Dis</source> (<year>2015</year>) <volume>60</volume>:<page-range>764&#x2013;72</page-range>. doi: <pub-id pub-id-type="doi">10.1093/cid/ciu945</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Srividya</surname> <given-names>G</given-names>
</name>
<name>
<surname>Nikhila</surname> <given-names>GPS</given-names>
</name>
<name>
<surname>Kaushik</surname> <given-names>AV</given-names>
</name>
<name>
<surname>Jayachandran</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Immune thrombocytopenia in tuberculosis: causal or coincidental</article-title>? <source>J Glob Infect Dis</source> (<year>2014</year>) <volume>6</volume>:<page-range>128&#x2013;31</page-range>. doi: <pub-id pub-id-type="doi">10.4103/0974-777X.138512</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petruccioli</surname> <given-names>E</given-names>
</name>
<name>
<surname>Scriba</surname> <given-names>TJ</given-names>
</name>
<name>
<surname>Petrone</surname> <given-names>L</given-names>
</name>
<name>
<surname>Hatherill</surname> <given-names>M</given-names>
</name>
<name>
<surname>Cirillo</surname> <given-names>DM</given-names>
</name>
<name>
<surname>Joosten</surname> <given-names>SA</given-names>
</name>
<etal/>
</person-group>. <article-title>Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis</article-title>. <source>Eur Respir J</source> (<year>2016</year>) <volume>48</volume>:<page-range>1751&#x2013;63</page-range>. doi: <pub-id pub-id-type="doi">10.1183/13993003.01012-2016</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khan</surname> <given-names>N</given-names>
</name>
<name>
<surname>Downey</surname> <given-names>J</given-names>
</name>
<name>
<surname>Sanz</surname> <given-names>J</given-names>
</name>
<name>
<surname>Kaufmann</surname> <given-names>E</given-names>
</name>
<name>
<surname>Blankenhaus</surname> <given-names>B</given-names>
</name>
<name>
<surname>Pacis</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Tuberculosis reprograms hematopoietic stem cells to limit myelopoiesis and impair trained immunity</article-title>. <source>Cell</source> (<year>2020</year>) <volume>183</volume>:<fpage>752</fpage>&#x2013;<lpage>770.e22</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2020.09.062</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O&#x2019;Garra</surname> <given-names>A</given-names>
</name>
<name>
<surname>Redford</surname> <given-names>PS</given-names>
</name>
<name>
<surname>McNab</surname> <given-names>FW</given-names>
</name>
<name>
<surname>Bloom</surname> <given-names>CI</given-names>
</name>
<name>
<surname>Wilkinson</surname> <given-names>RJ</given-names>
</name>
<name>
<surname>Berry</surname> <given-names>MPR</given-names>
</name>
</person-group>. <article-title>The immune response in tuberculosis</article-title>. <source>Annu Rev Immunol</source> (<year>2013</year>) <volume>31</volume>:<fpage>475</fpage>&#x2013;<lpage>527</lpage>. doi: <pub-id pub-id-type="doi">10.1146/annurev-immunol-032712-095939</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Norris</surname> <given-names>BA</given-names>
</name>
<name>
<surname>Ernst</surname> <given-names>JD</given-names>
</name>
</person-group>. <article-title>Mononuclear cell dynamics in m. tuberculosis infection provide opportunities for therapeutic intervention</article-title>. <source>PloS Pathog</source> (<year>2018</year>) <volume>14</volume>:<elocation-id>e1007154</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1007154</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moreira-Teixeira</surname> <given-names>L</given-names>
</name>
<name>
<surname>Tabone</surname> <given-names>O</given-names>
</name>
<name>
<surname>Graham</surname> <given-names>CM</given-names>
</name>
<name>
<surname>Singhania</surname> <given-names>A</given-names>
</name>
<name>
<surname>Stavropoulos</surname> <given-names>E</given-names>
</name>
<name>
<surname>Redford</surname> <given-names>PS</given-names>
</name>
<etal/>
</person-group>. <article-title>Mouse transcriptome reveals potential signatures of protection and pathogenesis in human tuberculosis</article-title>. <source>Nat Immunol</source> (<year>2020</year>) <volume>21</volume>:<page-range>464&#x2013;76</page-range>. doi: <pub-id pub-id-type="doi">10.1038/s41590-020-0610-z</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fonseca</surname> <given-names>KL</given-names>
</name>
<name>
<surname>Maceiras</surname> <given-names>AR</given-names>
</name>
<name>
<surname>Matos</surname> <given-names>R</given-names>
</name>
<name>
<surname>Simoes-Costa</surname> <given-names>L</given-names>
</name>
<name>
<surname>Sousa</surname> <given-names>J</given-names>
</name>
<name>
<surname>C&#xe1;</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Deficiency in the glycosyltransferase Gcnt1 increases susceptibility to tuberculosis through a mechanism involving neutrophils</article-title>. <source>Mucosal Immunol</source> (<year>2020</year>) <volume>13</volume>:<page-range>836&#x2013;48</page-range>. doi: <pub-id pub-id-type="doi">10.1038/s41385-020-0277-7</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moreira-Teixeira</surname> <given-names>L</given-names>
</name>
<name>
<surname>Sousa</surname> <given-names>J</given-names>
</name>
<name>
<surname>McNab</surname> <given-names>FW</given-names>
</name>
<name>
<surname>Torrado</surname> <given-names>E</given-names>
</name>
<name>
<surname>Cardoso</surname> <given-names>F</given-names>
</name>
<name>
<surname>Machado</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Type I IFN inhibits alternative macrophage activation during mycobacterium tuberculosis infection and leads to enhanced protection in the absence of IFN-&#x3b3; signaling</article-title>. <source>J Immunol</source> (<year>2016</year>) <volume>197</volume>:<page-range>4714&#x2013;26</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.1600584</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McInnes</surname> <given-names>L</given-names>
</name>
<name>
<surname>Healy</surname> <given-names>J</given-names>
</name>
<name>
<surname>Saul</surname> <given-names>N</given-names>
</name>
<name>
<surname>Gro&#xdf;berger</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>UMAP: uniform manifold approximation and projection</article-title>. <source>J Open Source Softw</source> (<year>2018</year>) <volume>3</volume>:<fpage>861</fpage>. doi: <pub-id pub-id-type="doi">10.21105/joss.00861</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moreira-Teixeira</surname> <given-names>L</given-names>
</name>
<name>
<surname>Stimpson</surname> <given-names>PJ</given-names>
</name>
<name>
<surname>Stavropoulos</surname> <given-names>E</given-names>
</name>
<name>
<surname>Hadebe</surname> <given-names>S</given-names>
</name>
<name>
<surname>Chakravarty</surname> <given-names>P</given-names>
</name>
<name>
<surname>Ioannou</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Type I IFN exacerbates disease in tuberculosis-susceptible mice by inducing neutrophil-mediated lung inflammation and NETosis</article-title>. <source>Nat Commun</source> (<year>2020</year>) <volume>11</volume>:<fpage>5566</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-020-19412-6</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schneider</surname> <given-names>CA</given-names>
</name>
<name>
<surname>Rasband</surname> <given-names>WS</given-names>
</name>
<name>
<surname>Eliceiri</surname> <given-names>KW</given-names>
</name>
</person-group>. <article-title>NIH Image to ImageJ: 25 years of image analysis</article-title>. <source>Nat Methods</source> (<year>2012</year>) <volume>9</volume>:<page-range>671&#x2013;5</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nmeth.2089</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schindelin</surname> <given-names>J</given-names>
</name>
<name>
<surname>Arganda-Carreras</surname> <given-names>I</given-names>
</name>
<name>
<surname>Frise</surname> <given-names>E</given-names>
</name>
<name>
<surname>Kaynig</surname> <given-names>V</given-names>
</name>
<name>
<surname>Longair</surname> <given-names>M</given-names>
</name>
<name>
<surname>Pietzsch</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Fiji: An open-source platform for biological-image analysis</article-title>. <source>Nat Methods</source> (<year>2012</year>) <volume>9</volume>:<page-range>676&#x2013;82</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sousa</surname> <given-names>J</given-names>
</name>
<name>
<surname>C&#xe1;</surname> <given-names>B</given-names>
</name>
<name>
<surname>Maceiras</surname> <given-names>AR</given-names>
</name>
<name>
<surname>Sim&#xf5;es-Costa</surname> <given-names>L</given-names>
</name>
<name>
<surname>Fonseca</surname> <given-names>KL</given-names>
</name>
<name>
<surname>Fernandes</surname> <given-names>AI</given-names>
</name>
<etal/>
</person-group>. <article-title>Mycobacterium tuberculosis associated with severe tuberculosis evades cytosolic surveillance systems and modulates IL-1&#x3b2; production</article-title>. <source>Nat Commun</source> (<year>2020</year>) <volume>11</volume>:<fpage>1949</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-020-15832-6</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vierboom</surname> <given-names>MPM</given-names>
</name>
<name>
<surname>Dijkman</surname> <given-names>K</given-names>
</name>
<name>
<surname>Sombroek</surname> <given-names>CC</given-names>
</name>
<name>
<surname>Hofman</surname> <given-names>SO</given-names>
</name>
<name>
<surname>Boot</surname> <given-names>C</given-names>
</name>
<name>
<surname>Vervenne</surname> <given-names>RAW</given-names>
</name>
<etal/>
</person-group>. <article-title>Stronger induction of trained immunity by mucosal BCG or MTBVAC vaccination compared to standard intradermal vaccination</article-title>. <source>Cell Rep Med</source> (<year>2021</year>) <volume>2</volume>:<fpage>100185</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.xcrm.2020.100185</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kleinnijenhuis</surname> <given-names>J</given-names>
</name>
<name>
<surname>Quintin</surname> <given-names>J</given-names>
</name>
<name>
<surname>Preijers</surname> <given-names>F</given-names>
</name>
<name>
<surname>Joosten</surname> <given-names>LAB</given-names>
</name>
<name>
<surname>Jacobs</surname> <given-names>C</given-names>
</name>
<name>
<surname>Xavier</surname> <given-names>RJ</given-names>
</name>
<etal/>
</person-group>. <article-title>BCG-Induced trained immunity in NK cells: role for non-specific protection to infection</article-title>. <source>Clin Immunol</source> (<year>2014</year>) <volume>155</volume>:<page-range>213&#x2013;9</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.clim.2014.10.005</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Joosten</surname> <given-names>SA</given-names>
</name>
<name>
<surname>van Meijgaarden</surname> <given-names>KE</given-names>
</name>
<name>
<surname>Arend</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Prins</surname> <given-names>C</given-names>
</name>
<name>
<surname>Oftung</surname> <given-names>F</given-names>
</name>
<name>
<surname>Korsvold</surname> <given-names>GE</given-names>
</name>
<etal/>
</person-group>. <article-title>Mycobacterial growth inhibition is associated with trained innate immunity</article-title>. <source>J Clin Invest</source> (<year>2018</year>) <volume>128</volume>:<page-range>1837&#x2013;51</page-range>. doi: <pub-id pub-id-type="doi">10.1172/JCI97508</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Bruin</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Voermans</surname> <given-names>C</given-names>
</name>
<name>
<surname>Nolte</surname> <given-names>MA</given-names>
</name>
</person-group>. <article-title>Impact of interferon-&#x3b3; on hematopoiesis</article-title>. <source>Blood</source> (<year>2014</year>) <volume>124</volume>:<page-range>2479&#x2013;86</page-range>. doi: <pub-id pub-id-type="doi">10.1182/blood-2014-04-568451</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morales-Mantilla</surname> <given-names>DE</given-names>
</name>
<name>
<surname>King</surname> <given-names>KY</given-names>
</name>
</person-group>. <article-title>The role of interferon-gamma in hematopoietic stem cell development, homeostasis, and disease</article-title>. <source>Curr Stem Cell Rep</source> (<year>2018</year>) <volume>4</volume>:<page-range>264&#x2013;71</page-range>. doi: <pub-id pub-id-type="doi">10.1007/s40778-018-0139-3</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mitroulis</surname> <given-names>I</given-names>
</name>
<name>
<surname>Kalafati</surname> <given-names>L</given-names>
</name>
<name>
<surname>Bornh&#xe4;user</surname> <given-names>M</given-names>
</name>
<name>
<surname>Hajishengallis</surname> <given-names>G</given-names>
</name>
<name>
<surname>Chavakis</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Regulation of the bone marrow niche by inflammation</article-title>. <source>Front Immunol</source> (<year>2020</year>) <volume>11</volume>:<elocation-id>1540</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2020.01540</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Borkute</surname> <given-names>RR</given-names>
</name>
<name>
<surname>Woelke</surname> <given-names>S</given-names>
</name>
<name>
<surname>Pei</surname> <given-names>G</given-names>
</name>
<name>
<surname>Dorhoi</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Neutrophils in tuberculosis: cell biology, cellular networking and multitasking in host defense</article-title>. <source>Int J Mol Sci</source> (<year>2021</year>) <volume>22</volume>:<fpage>4801&#x2013;24</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms22094801</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muefong</surname> <given-names>CN</given-names>
</name>
<name>
<surname>Sutherland</surname> <given-names>JS</given-names>
</name>
</person-group>. <article-title>Neutrophils in tuberculosis-associated inflammation and lung pathology</article-title>. <source>Front Immunol</source> (<year>2020</year>) <volume>11</volume>:<elocation-id>962</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2020.00962</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berry</surname> <given-names>MPR</given-names>
</name>
<name>
<surname>Graham</surname> <given-names>CM</given-names>
</name>
<name>
<surname>McNab</surname> <given-names>FW</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Bloch</surname> <given-names>SAA</given-names>
</name>
<name>
<surname>Oni</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis</article-title>. <source>Nature</source> (<year>2010</year>) <volume>466</volume>:<page-range>973&#x2013;7</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nature09247</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scriba</surname> <given-names>TJ</given-names>
</name>
<name>
<surname>Penn-Nicholson</surname> <given-names>A</given-names>
</name>
<name>
<surname>Shankar</surname> <given-names>S</given-names>
</name>
<name>
<surname>Hraha</surname> <given-names>T</given-names>
</name>
<name>
<surname>Thompson</surname> <given-names>EG</given-names>
</name>
<name>
<surname>Sterling</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Sequential inflammatory processes define human progression from m. tuberculosis infection to tuberculosis disease</article-title>. <source>PloS Pathog</source> (<year>2017</year>) <volume>13</volume>:<elocation-id>e1006687</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1006687</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boettcher</surname> <given-names>S</given-names>
</name>
<name>
<surname>Manz</surname> <given-names>MG</given-names>
</name>
</person-group>. <article-title>Regulation of inflammation- and infection-driven hematopoiesis</article-title>. <source>Trends Immunol</source> (<year>2017</year>) <volume>38</volume>:<page-range>345&#x2013;57</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.it.2017.01.004</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manca</surname> <given-names>C</given-names>
</name>
<name>
<surname>Tsenova</surname> <given-names>L</given-names>
</name>
<name>
<surname>Bergtold</surname> <given-names>A</given-names>
</name>
<name>
<surname>Freeman</surname> <given-names>S</given-names>
</name>
<name>
<surname>Tovey</surname> <given-names>M</given-names>
</name>
<name>
<surname>Musser</surname> <given-names>JM</given-names>
</name>
<etal/>
</person-group>. <article-title>Virulence of a mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha/beta</article-title>. <source>Proc Natl Acad Sci USA</source> (<year>2001</year>) <volume>98</volume>:<page-range>5752&#x2013;7</page-range>. doi: <pub-id pub-id-type="doi">10.1073/pnas.091096998</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ordway</surname> <given-names>D</given-names>
</name>
<name>
<surname>Henao-Tamayo</surname> <given-names>M</given-names>
</name>
<name>
<surname>Harton</surname> <given-names>M</given-names>
</name>
<name>
<surname>Palanisamy</surname> <given-names>G</given-names>
</name>
<name>
<surname>Troudt</surname> <given-names>J</given-names>
</name>
<name>
<surname>Shanley</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>The hypervirulent mycobacterium tuberculosis strain HN878 induces a potent TH1 response followed by rapid down-regulation</article-title>. <source>J Immunol</source> (<year>2007</year>) <volume>179</volume>:<page-range>522&#x2013;31</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.179.1.522</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Jeyanathan</surname> <given-names>M</given-names>
</name>
<name>
<surname>Haddadi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Barra</surname> <given-names>NG</given-names>
</name>
<name>
<surname>Vaseghi-Shanjani</surname> <given-names>M</given-names>
</name>
<name>
<surname>Damjanovic</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Induction of autonomous memory alveolar macrophages requires T cell help and is critical to trained immunity</article-title>. <source>Cell</source> (<year>2018</year>) <volume>175</volume>:<fpage>1634</fpage>&#x2013;<lpage>1650.e17</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2018.09.042</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aegerter</surname> <given-names>H</given-names>
</name>
<name>
<surname>Kulikauskaite</surname> <given-names>J</given-names>
</name>
<name>
<surname>Crotta</surname> <given-names>S</given-names>
</name>
<name>
<surname>Patel</surname> <given-names>H</given-names>
</name>
<name>
<surname>Kelly</surname> <given-names>G</given-names>
</name>
<name>
<surname>Hessel</surname> <given-names>EM</given-names>
</name>
<etal/>
</person-group>. <article-title>Influenza-induced monocyte-derived alveolar macrophages confer prolonged antibacterial protection</article-title>. <source>Nat Immunol</source> (<year>2020</year>) <volume>21</volume>:<page-range>145&#x2013;57</page-range>. doi: <pub-id pub-id-type="doi">10.1038/s41590-019-0568-x</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>T</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Influenza-trained mucosal-resident alveolar macrophages confer long-term antitumor immunity in the lungs</article-title>. <source>Nat Immunol</source> (<year>2023</year>) <volume>24</volume>:<page-range>423&#x2013;38</page-range>. doi: <pub-id pub-id-type="doi">10.1038/s41590-023-01428-x</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nandi</surname> <given-names>B</given-names>
</name>
<name>
<surname>Behar</surname> <given-names>SM</given-names>
</name>
</person-group>. <article-title>Regulation of neutrophils by interferon-&#x3b3; limits lung inflammation during tuberculosis infection</article-title>. <source>J Exp Med</source> (<year>2011</year>) <volume>208</volume>:<page-range>2251&#x2013;62</page-range>. doi: <pub-id pub-id-type="doi">10.1084/jem.20110919</pub-id>
</citation>
</ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wallis</surname> <given-names>RS</given-names>
</name>
<name>
<surname>O&#x2019;Garra</surname> <given-names>A</given-names>
</name>
<name>
<surname>Sher</surname> <given-names>A</given-names>
</name>
<name>
<surname>Wack</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Host-directed immunotherapy of viral and bacterial infections: past, present and future</article-title>. <source>Nat Rev Immunol</source> (<year>2023</year>) <volume>23</volume>:<page-range>121&#x2013;33</page-range>. doi: <pub-id pub-id-type="doi">10.1038/s41577-022-00734-z</pub-id>
</citation>
</ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tiwari</surname> <given-names>D</given-names>
</name>
<name>
<surname>Martineau</surname> <given-names>AR</given-names>
</name>
</person-group>. <article-title>Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies</article-title>. <source>Semin Immunol</source> (<year>2023</year>) <volume>65</volume>:<fpage>101672</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.smim.2022.101672</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>